Search For "glycemic control"
Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3
Updated : 1 year, 1 month ago IST
According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3 trial."
Read More
Study: Glycemic control in patients with type 2 diabetes can be predicted
Updated : 3 years, 4 months ago IST
Machine learning techniques can predict with certainty the likelihood that patients with type 2 diabetes would have poor glycemic control. The length of type 2 diabetes, previous glucose levels, and the patient's use of anti-diabetic medications are the most crucial variables influencing gly
Read More
Glenmark launches drug for treating type 2 diabetes
Updated : 3 years, 5 months ago IST
This fixed-dose combination has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg), Pioglitazone (15 mg) and Metformin (500mg/1000mg) in a sustained release (SR) formulation, according to the company's statement. It offers patients with type 2 diabetes the con
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 5 years, 4 months ago IST
Mumbai (Maharashtra) [India], December 29 . (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination (FDC) of its novel, patent protected and globally researched Sodium Glucose Co-Transporter Inhibitor (
Read More
People with type 2 diabetes need not avoid eating potatoes based on glycem
Updated : 5 years, 6 months ago IST
Washington [US], October 26 (ANI): New study findings show that people with type 2 diabetes can better maintain overnight glycemic control when high Glycemic Index (GI) potatoes are included in an evening meal versus low GI basmati rice.
Read More
DayTwo to Scale Microbiome research platform with USD 31 million financing
Updated : 6 years, 10 months ago IST
San Francisco (California) [USA] July 03 (ANI/NewsVoir): DayTwo, the microbiome human discovery platform that offers a glycemic control solution for people with type 2 diabetes, announced USD 31 million in Series B financing.
Read More